phentolamine

(redirected from Phentolamine mesylate)
Also found in: Dictionary, Medical.
Related to Phentolamine mesylate: Regitine
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for phentolamine

a virility drug (trade name Vasomax) to treat erectile dysfunction in men

References in periodicals archive ?
3) The combination of Katz's and Weber's knowledge led to the development of phentolamine mesylate to counter the effects of the vasoconstrictor epinephrine.
Therefore, phentolamine mesylate has not been tested for efficacy following use of local anesthetic without added vasoconstrictors.
Vasomax(R) is the Company's first product, an oral treatment for Male Erectile Dysfunction (MED) that is a proprietary form of phentolamine mesylate delivered in a rapidly disintegrating tablet.
Vasomax(R) is Zonagen's rapidly disintegrating oral formulation of phentolamine mesylate for the treatment of male erectile dysfunction that is currently under regulatory review by the U.
Phentolamine mesylate (a vasodilator), the active ingredient in the investigational agent NV-101, has been approved and in use in specific medical indications at significantly higher doses for over 50 years.
for Vasomax(R), Zonagen's rapidly disintegrating oral formulation of phentolamine mesylate for male erectile dysfunction.
The study, conducted by the Chicago Center for Clinical Research, is designed to evaluate the safety and pharmacokinetics of phentolamine mesylate in sixty healthy patients.
Vasomax(R), Zonagen's rapidly-disintegrating oral formulation of phentolamine mesylate, was licensed worldwide to Schering-Plough Corporation on November 17, 1997 for the treatment of male erectile dysfunction.
Vasomax(TM), Zonagen's rapidly-disintegrating oral formulation of phentolamine mesylate, has been tested in over 300 men in Mexico and more than 3,000 men in the U.
Invicorp(R) is a patented injectable combination of phentolamine mesylate and vasoactive intestinal polypeptide.
Invicorp(R) is Senetek's patented injectable combination of phentolamine mesylate and vasoactive intestinal polypeptide for the treatment of ED.